JP2025513753A5 - - Google Patents

Info

Publication number
JP2025513753A5
JP2025513753A5 JP2024557969A JP2024557969A JP2025513753A5 JP 2025513753 A5 JP2025513753 A5 JP 2025513753A5 JP 2024557969 A JP2024557969 A JP 2024557969A JP 2024557969 A JP2024557969 A JP 2024557969A JP 2025513753 A5 JP2025513753 A5 JP 2025513753A5
Authority
JP
Japan
Prior art keywords
cov
sars
polynucleotide
natural
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024557969A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025513753A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/058069 external-priority patent/WO2023186946A1/en
Publication of JP2025513753A publication Critical patent/JP2025513753A/ja
Publication of JP2025513753A5 publication Critical patent/JP2025513753A5/ja
Pending legal-status Critical Current

Links

JP2024557969A 2022-03-28 2023-03-28 ワントゥーストップ（ｏｎｅ－ｔｏ－ｓｔｏｐ）弱毒化ＳＡＲＳ－ＣｏＶ－２ウイルス Pending JP2025513753A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP22164874 2022-03-28
EP22164874.4 2022-03-28
EP22201198.3 2022-10-12
EP22201198 2022-10-12
PCT/EP2023/058069 WO2023186946A1 (en) 2022-03-28 2023-03-28 One-to-stop attenuated sars-cov-2 virus

Publications (2)

Publication Number Publication Date
JP2025513753A JP2025513753A (ja) 2025-04-30
JP2025513753A5 true JP2025513753A5 (enExample) 2026-04-08

Family

ID=85980679

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024557969A Pending JP2025513753A (ja) 2022-03-28 2023-03-28 ワントゥーストップ（ｏｎｅ－ｔｏ－ｓｔｏｐ）弱毒化ＳＡＲＳ－ＣｏＶ－２ウイルス

Country Status (10)

Country Link
US (1) US20250295757A1 (enExample)
EP (1) EP4499141A1 (enExample)
JP (1) JP2025513753A (enExample)
KR (1) KR20240163164A (enExample)
CN (1) CN119136829A (enExample)
AU (1) AU2023244474A1 (enExample)
CA (1) CA3244307A1 (enExample)
IL (1) IL315075A (enExample)
MX (1) MX2024011903A (enExample)
WO (1) WO2023186946A1 (enExample)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115427073A (zh) * 2020-01-28 2022-12-02 科达金尼克斯有限公司 去优化SARS-CoV-2及其方法和用途

Similar Documents

Publication Publication Date Title
JP2023512519A5 (enExample)
JP7846986B2 (ja) 生物学的製剤の投与のためのアルファウイルスベースのレプリコン
JP2023519640A5 (enExample)
KR100996330B1 (ko) Ｈｉｖ 조절/부속 단백질의 융합 단백질
TWI828168B (zh) 用作b型肝炎病毒(hbv)疫苗之自我複製rna分子及其用途
JP2014527404A5 (enExample)
JP2013501038A5 (enExample)
JP5740473B2 (ja) ヒトパピローマウイルス変形体及び免疫増強剤を含む子宮頸癌の予防または治療用組成物
RU2012107671A (ru) Композиция для лечения инфекции вирусом гепатита в
WO2003059381A2 (en) Immunogenic preparations and vaccines on the basis of mrna
JP2022505877A5 (enExample)
US10435712B2 (en) Evolution of high-titer virus-like vesicles for vaccine applications
JP2002542827A5 (enExample)
JP2005511019A5 (enExample)
JP2004501646A5 (enExample)
Wiener et al. Evolution of reovirus genes: a comparison of serotype 1, 2, and 3 M2 genome segments, which encode the major structural capsid protein μ1C
KR20110044971A (ko) 신규 융합 단백질과 상기 단백질의 ｃ형 간염 백신으로의 사용
CN107759673B (zh) 可对hbv的dna进行表观甲基化修饰的蛋白分子及其应用
JP7163547B2 (ja) 新規ペプチドおよびその用途
KR101756131B1 (ko) 간세포 성장인자 및 기질세포 유발인자1알파를 이용한 말초동맥질환의 예방 또는 치료용 조성물
JP2004121266A (ja) コンビナトリアルポリペプチド抗原
WO2015042187A1 (en) Treatment of hepatitis d virus infections by redirection of t cells
KR102384683B1 (ko) 구제역 바이러스 억제 활성을 갖는 신규한 돼지 인터페론-알파 융합 단백질 및 이의 용도
JP2002538775A5 (enExample)
RU2024129737A (ru) Вирус sars-cov-2, аттенуированный с использованием "one-to-stop"